Table of Contents
From the Editor
- New practice guidelines: Constrained or enhanced by the evidence?
The new guidelines on cholesterol and hypertension are more evidence-based, but will they help improve outcomes?
1-Minute Consult
- Is hemoglobin A1c an accurate measure of glycemic control in all diabetic patients?
Regard its values with suspicion, especially when they do not agree with the patient’s blood glucose levels.
Current Drug Therapy
- Hepatitis C virus: Here comes all-oral treatment
Direct-acting antiviral drugs open the door for an all-oral regimen, potentially eliminating the need for interferon and thus avoiding its harsh side effects.
Editorial
- When are effective medications just too expensive?
Physicians may have been taught that it isn’t their job to think about costs—but they should.
Review
- New hypertension guidelines: One size fits most?
The new report is more evidence-based and focused, outlining a strategy that is simpler and, in some instances, less aggressive.
- Prevention and treatment of influenza in the primary care office
Fewer than half of eligible US residents get vaccinated. Here is a review of the barriers and the new options.
Letters to the Editor
- Problems with myocardial infarction definitions
Readers comment on problems with the definition of myocardial infarction (December 2013) and on the diagnosis of myasthenia gravis (November 2013).
- In reply: Problems with myocardial infarction definitions
Readers comment on problems with the definition of myocardial infarction (December 2013) and on the diagnosis of myasthenia gravis (November 2013).
- Myasthenia gravis
Readers comment on problems with the definition of myocardial infarction (December 2013) and on the diagnosis of myasthenia gravis (November 2013).
- In reply: Myasthenia gravis
Readers comment on problems with the definition of myocardial infarction (December 2013) and on the diagnosis of myasthenia gravis (November 2013).